The economic benefits of ending the COVID-19 pandemic even one day earlier are enormous. Michael Kremer and Canice Prendergast describe the urgency of vaccine delivery, the promise of production incentives, and why it pays to fail when developing a vaccine.

View All Episodes

More on this topic

Research Briefs·Mar 7, 2024

What Drives Inflation? Lessons from Disaggregated Price Data

Elisa Rubbo
US inflation in the early phases of the COVID pandemic was entirely driven by disruptions in supply and demand across industries, whereas most of the subsequent increase in consumer prices is driven by aggregate demand.
Topics: COVID-19, Monetary Policy
Research Briefs·Feb 1, 2024

Quantifying the Social Value of a Universal COVID-19 Vaccine and Incentivizing Its Development

Rachel Glennerster, Thomas Kelly, Claire T. McMahon and Christopher M. Snyder
A universal COVID-19 vaccine that is effective against existing and future variants could provide the United States population with $1.5–$2.6 trillion more in social value than variant-specific boosters. The social value of a universal vaccine eclipses the cost of incentivizing...
Topics: COVID-19
Research Briefs·Nov 15, 2023

Greater Than the Sum of Its Parts: Aggregate vs. Aggregated Inflation Expectations

Alexander Dietrich, Edward S. Knotek II, Kristian O. Myrseth, Robert W. Rich, Raphael Schoenle and Michael Weber
A novel measure of consumer inflation expectations that is constructed by combining forecasts from across different categories of consumption is consistently lower than conventional measures. It is also less volatile and a stronger predictor of consumers’ spending plans.
Topics: COVID-19